Table 1.
Demographic and Clinical Characteristics of the patients in the study
| Patient characteristics | All patients (N = 117) | |
|---|---|---|
| Age | Median (IQR) years | 47 (28–68) |
| Sex-male | n (%) | 100 (77) |
| Trauma type | ||
| TBI | n (%) | 58 (50) |
| Pelvic/lower limb fracture | n (%) | 32 (27) |
| Spinal cord injury | n (%) | 10 (9) |
| Risk factor for DVT | ||
| Known h/o DVT/PE | n (%) | 4 (3) |
| Femoral CVC present | n (%) | 26 (22) |
| Location of femoral CVC-right | n (%) | 23 (88) |
| Severity of Illness Scores | ||
| ISS score | Mean (SD) | 27.5 (9.53) |
| APACHE II Score | Median (IQR) | 14 (10–19) |
| DVT prophylaxis | ||
| Calf compression devices | n (%) | 103 (88) |
| Compression stockings | n (%) | 106 (91) |
| Enoxaparin** | n (%) | 13 (11) |
| Mechanical ventilation | n (%) | 86 (74) |
| Duration of mechanical ventilation | Median (IQR) days | 5.4 (2.4–9.5) |
| ICU length of stay | Median (IQR) days | 6.6 (3.2–11.6) |
| Hospital length of stay* | Median (IQR) days | 17 (11–22) |
| Survival | n (%) | 104 (89) |
IQR interquartile rage, SD standard deviation, TBI traumatic brain injury, DVT deep vein thrombosis, PE pulmonary embolism, CVC central venous catheter, ISS injury severity score, APACHE II Acute Physiology and Chronic Health Evaluation II
*Data missing for 2 patients
**1 patient received unfractionated heparin